Jefferies Financial Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100,000
Closed -$110K 1520
2025
Q1
$110K Hold
100,000
﹤0.01% 1459
2024
Q4
$90.5K Buy
+100,000
New +$85.7K ﹤0.01% 1469
2024
Q2
Sell
-53,600
Closed -$63.2K 1573
2024
Q1
$63.2K Buy
+53,600
New +$59K ﹤0.01% 1479
2023
Q1
Sell
-100,000
Closed -$217K 1755
2022
Q4
$217K Buy
+100,000
New +$823K ﹤0.01% 1280

Other funds holding GOSS

Jefferies Financial Group's GOSS Position: Q2 2025 in Review

Jefferies Financial Group sold out of Gossamer Bio (GOSS) in Q2 2025, closing a stake of 100,000 shares — an estimated $110K sold.

Jefferies Financial Group first reported a position in GOSS in Q4 2022 and held it in 4 quarters. The position peaked at $217K in Q4 2022. 123 funds tracked by Wall St. Rank hold GOSS as of Q2 2025.

  • Jefferies Financial Group reported no remaining Gossamer Bio position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 100,000 Gossamer Bio shares in Q2 2025, an estimated $110K.
  • Jefferies Financial Group first reported a position in Gossamer Bio in Q4 2022 and held it in 4 quarters.
  • Jefferies Financial Group's Gossamer Bio position peaked at $217K in Q4 2022.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.